{
  "alleleExist":true,
  "dataVersion":"v4.5",
  "diagnosticImplications":[],
  "diagnosticSummary":"",
  "geneExist":true,
  "geneSummary":"SMAD4 encodes a tumor suppressor and transcription factor that is a downstream effector in the TGF-\u00df signal transduction pathway. SMAD4 is frequently mutated in pancreatic and colorectal cancer and infrequently mutated in various other cancers.",
  "highestDiagnosticImplicationLevel":null,
  "highestFdaLevel":null,
  "highestPrognosticImplicationLevel":null,
  "highestResistanceLevel":null,
  "highestSensitiveLevel":null,
  "hotspot":true,
  "lastUpdate":"02/02/2023",
  "mutationEffect":{
    "citations":{
      "abstracts":[],
      "pmids":[
        "11779503",
        "17132729",
        "11274206"
      ]
    },
    "description":"The SMAD4 R361H mutation is located in the MH2 domain, which is an interaction surface for SMAD4 binding partners. In biochemical assays, this mutation decreased the ability of SMAD4 to interact with SMAD2, resulting in decreased anti-proliferative TGF\u00df-mediated transcription (PMID: 11779503, 11274206, 17132729).",
    "knownEffect":"Loss-of-function"
  },
  "oncogenic":"Likely Oncogenic",
  "otherSignificantResistanceLevels":[],
  "otherSignificantSensitiveLevels":[],
  "prognosticImplications":[],
  "prognosticSummary":"",
  "query":{
    "alteration":"R361H",
    "alterationType":null,
    "consequence":null,
    "entrezGeneId":4089,
    "hgvs":null,
    "hugoSymbol":"SMAD4",
    "id":null,
    "proteinEnd":null,
    "proteinStart":null,
    "referenceGenome":"GRCh38",
    "svType":null,
    "tumorType":null
  },
  "treatments":[],
  "tumorTypeSummary":"",
  "variantExist":true,
  "variantSummary":"The SMAD4 R361H mutation is likely oncogenic.",
  "vus":true
}